HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Orexin AHPLC ≥ 99%MS confirmed10mg
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | Orexin A |
|---|---|
| CAS number | 205640-90-0 |
| Molecular formula | C152H243N47O44S4 |
| Molecular weight | 3561.1 g/mol |
| Sequence | pGlu-PLPDCCRQKTCSCRLYELLHGAGNHAAGILTL-NH2 (33 aa; disulfide bonds Cys6-Cys12 and Cys7-Cys14; N-terminal pyroglutamate, C-terminal amide) |
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 10mg / 20mg |
| Documentation | Batch-document availability confirmed by product, specification and applicable lot |
| Distribution scope | Research use, worldwide |
| Storage | Store lyophilized Orexin A at -20°C, protected from light and moisture; the sealed powder is stable long-term when kept cold. After reconstitution, keep refrigerated, use within a short window, and avoid repeated freeze-thaw cycles. |
MOQ & lead time
| Tier | Quantity | Lead time |
|---|---|---|
| OEM lot | 50 kits (500 vials) | 3–7 days |
| Production lot | 500–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Supplied as a research-use peptide. Every quote confirms current-batch COA, purity, destination market and buyer track before invoicing.
Overview
About Orexin A.
Orexin A (hypocretin-1) is an endogenous 33-residue neuropeptide that acts as an agonist at both orexin receptors, OX1R and OX2R. Through this receptor signaling it is studied for its role in the regulation of wakefulness, arousal, and appetite in research models.
Documentation
Batch documentation support for Orexin A lots.
batch-document availability confirmed by product, specification and applicable lot. Distribution scope confirmed before invoicing.
MS identity
Mass spectrometry identity confirmation against the Orexin A reference profile.
Lot traceability
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
Orexin A — frequently asked by B2B buyers.
What format and vial sizes is Orexin A supplied in?
Pepti supplies Orexin A as a research-use lyophilized (freeze-dried) powder in 10 mg and 20 mg vials. Custom fill sizes and bulk quantities can be quoted on RFQ.
What documentation ships with each lot?
For the applicable lot, Pepti confirms the available document set during RFQ review. Depending on the product and lot, the set can include a Certificate of Analysis showing HPLC purity and mass-spectrometry (MS) identity confirmation. Additional lot documentation and specifications are available on request for B2B and private-label buyers.
What is the minimum order quantity, and can you private-label?
Standard MOQ is 50 kits (500 vials). As an OEM/private-label supplier, Pepti can provide custom labeling, packaging, and documentation for brand buyers; details are arranged under RFQ.
What purity is Orexin A tested to?
Purity is verified per lot by HPLC, with peptide identity confirmed by mass spectrometry. The exact purity value for a given batch is stated on that lot's Certificate of Analysis rather than assumed in advance.
Is Orexin A intended for therapeutic use?
No. Orexin A is supplied strictly for laboratory research and manufacturing use, not for consumer or veterinary consumption or applied use. Buyers are responsible for compliance with applicable regulations in their jurisdiction.
Related compounds
Related research peptides.
COA library search
Search public COAs for this product.
The public COA library is being expanded by product and specification. Use the search link below to check current public records for this item.